AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS: AXIM · Delayed Price · USD
0.0103
-0.0006 (-5.50%)
Apr 24, 2024, 3:36 PM EDT - Market closed
AXIM Biotechnologies Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 0.16 | 0.05 | 0.45 | 0.46 | 0.51 | 1.81 | 2.06 | 0.71 | 0.13 | 0.66 | Upgrade
|
Short-Term Investments | 0 | 0 | 0 | 0 | 0.24 | 0.15 | 0 | 0 | 0 | 0 | Upgrade
|
Cash & Cash Equivalents | 0.16 | 0.05 | 0.45 | 0.46 | 0.75 | 1.96 | 2.06 | 0.71 | 0.13 | 0.66 | Upgrade
|
Cash Growth | 230.90% | -89.56% | -0.92% | -39.27% | -61.50% | -4.97% | 188.48% | 431.67% | -79.71% | 520473.23% | Upgrade
|
Receivables | 0 | 0 | 0 | 0 | 0.32 | 0.01 | 0.01 | 0.51 | 0.01 | 0.01 | Upgrade
|
Inventory | 0 | 0 | 0 | 0 | 0.49 | 0.01 | 0.01 | 0.04 | 0.2 | 0 | Upgrade
|
Other Current Assets | 0 | 0.06 | 0.18 | 0.26 | 0.08 | 0.05 | 0.04 | 0.12 | 0.84 | 0.07 | Upgrade
|
Total Current Assets | 0.16 | 0.1 | 0.64 | 0.71 | 1.64 | 2.02 | 2.11 | 1.37 | 1.18 | 0.74 | Upgrade
|
Property, Plant & Equipment | 0.36 | 0.11 | 0.19 | 0.23 | 0 | 0.01 | 0.01 | 0.01 | 0.02 | 0 | Upgrade
|
Long-Term Investments | 0.02 | 0.05 | 0.1 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Goodwill | 0 | 0 | 0 | 2.46 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Intangible Assets | 3.59 | 3.99 | 4.38 | 7.8 | 0.05 | 0.05 | 0.06 | 0.06 | 0.06 | 0 | Upgrade
|
Other Long-Term Assets | 0.01 | -0.04 | 0.01 | 0.01 | 0 | 0.01 | 0.01 | 0 | 0 | 0 | Upgrade
|
Total Long-Term Assets | 3.99 | 4.11 | 4.69 | 10.6 | 0.05 | 0.07 | 0.08 | 0.08 | 0.08 | 0 | Upgrade
|
Total Assets | 4.15 | 4.21 | 5.32 | 11.31 | 1.69 | 2.09 | 2.19 | 1.45 | 1.26 | 0.74 | Upgrade
|
Accounts Payable | 2.78 | 1.32 | 0.91 | 1.07 | 0.77 | 0.22 | 0.44 | 0.4 | 0.39 | 0.14 | Upgrade
|
Deferred Revenue | 0.3 | 0.33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Current Debt | 0.09 | 0.02 | 1.64 | 0.4 | 1.05 | 1.02 | 5.63 | 0.97 | 1.05 | 1.05 | Upgrade
|
Other Current Liabilities | 2.8 | 1.72 | 0.03 | 0.03 | 1.57 | 2.09 | 1.63 | 1.65 | 1.11 | 0.12 | Upgrade
|
Total Current Liabilities | 5.98 | 3.39 | 2.58 | 1.5 | 3.4 | 3.32 | 7.71 | 3.02 | 2.56 | 1.32 | Upgrade
|
Long-Term Debt | 5.43 | 5.64 | 5.08 | 5.91 | 5.06 | 4.85 | 0.77 | 0.8 | 0.4 | 0 | Upgrade
|
Other Long-Term Liabilities | 0.37 | 0 | 0 | 2.34 | 0 | 0 | 0 | 0 | 0 | 1.19 | Upgrade
|
Total Long-Term Liabilities | 5.8 | 5.64 | 5.08 | 8.25 | 5.06 | 4.85 | 0.77 | 0.8 | 0.4 | 1.19 | Upgrade
|
Total Liabilities | 11.78 | 9.04 | 7.66 | 9.75 | 8.45 | 8.17 | 8.48 | 3.82 | 2.96 | 1.32 | Upgrade
|
Total Debt | 5.66 | 5.66 | 6.72 | 6.31 | 6.1 | 5.87 | 6.4 | 1.77 | 1.45 | 1.05 | Upgrade
|
Debt Growth | -0.11% | -15.69% | 6.49% | 3.38% | 4.02% | -8.34% | 261.16% | 22.24% | 38.10% | 2000.00% | Upgrade
|
Common Stock | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | Upgrade
|
Retained Earnings | -72.18 | -64.13 | -57.88 | -41.85 | -35.44 | -28.99 | -22.24 | -18.07 | -10.78 | -0.69 | Upgrade
|
Comprehensive Income | -0 | 0.14 | 4.53 | 0.2 | 0.05 | -0 | -0 | -0 | -0 | -0 | Upgrade
|
Shareholders' Equity | -7.63 | -4.83 | -2.34 | 1.57 | -6.76 | -6.08 | -6.28 | -2.37 | -1.7 | -0.58 | Upgrade
|
Total Liabilities and Equity | 4.15 | 4.21 | 5.32 | 11.31 | 1.69 | 2.09 | 2.19 | 1.45 | 1.26 | 0.74 | Upgrade
|
Net Cash / Debt | -5.5 | -5.62 | -6.27 | -5.85 | -5.35 | -3.91 | -4.34 | -1.06 | -1.32 | -0.39 | Upgrade
|
Net Cash Per Share | -0.02 | -0.03 | -0.05 | -0.05 | -0.09 | -0.07 | -0.08 | -0.03 | -0.04 | -0.01 | Upgrade
|
Working Capital | -5.82 | -3.29 | -1.94 | -0.78 | -1.76 | -1.3 | -5.59 | -1.64 | -1.37 | -0.58 | Upgrade
|
Book Value Per Share | -0.03 | -0.03 | -0.02 | 0.01 | -0.11 | -0.11 | -0.12 | -0.06 | -0.05 | -0.02 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.